AI-generated summary
The authors tested three light-based methods (photodynamic therapy at 660 nm, ultraviolet, and violet light) to inactivate bacteria in whole blood flowing through a thin transparent tube. They report 55-71% reduction of Staphylococcus aureus and 88-97% reduction of MRSA after 5 hours, with higher reductions when combined with immunocapture. PDT produced DNA damage markers in peripheral blood mononuclear cells, while violet and ultraviolet showed little, apart from a very low level of UV damage with ultraviolet.
- Who or what was studied
- Whole blood samples inoculated with Staphylococcus aureus and MRSA, with peripheral blood mononuclear cells assessed for genotoxicity; the abstract does not describe human participants.
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not state the number of blood samples or replicates and does not describe a clinical setting, so the findings are limited to laboratory conditions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Ultraviolet. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.